6,678 trials
Sinus Arrhythmia · Atrial Fibrillation
Primary: Number of Patients With Persistent Atrial Fibrillation (AF) After a Mean Follow-up of 15±7 Months: Comparison Between IAS and RAA Pacing in the Study Group — 2; 2; 9; 2…
Malaria
Primary: Number of Symptomatic Malaria Episode, RDT-confirmed, With Parasitemia ≥5000/μL (SMRC5000s) Per Person-year in Infants and Children (<5 Years) in Post Community…
Blepharitis
Primary: Improvement in Signs and Symptoms of Blepharitis — 15; 15 participants
Arthritis, Rheumatoid
Primary: Percentage of Participants in Remission at Week 28 — 87.5; 18.8 percentage of participants
Cradle Cap · Infantile Seborrheic Dermatitis
Primary: Subjects With Investigator Global Assessment (IGA) Success (IGA of 0 or 1) at End of Treatment (Day 7 or 14). — 91.7; 96 percentage of participants — p=>0.05
Pneumococcal Infections
Primary: Antibody Concentrations to the 7 Pneumococcal Serotypes Contained in Prevenar — 6.90; 7.16; 7.53; 9.45 μg/mL
Schizophrenia
Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 26 - Main Phase — -22.9 Units on a scale
Pulmonary Arterial Hypertension
Primary: Change From Baseline in the Total Distance Walked During 6 Minute Walk Time (6MWT) at Week 12 — 17.42; 14.08; 14.08; 13.62 Meters — p=0.5802
Hyperglycemia
Primary: Mean Blood Glucose of All Readings — 157.2; 181.8 mg/dL
Intervertebral Disk Degeneration · Intervertebral Disk Displacement · Ossification of Posterior Longitudinal Ligament
Primary: Bone Fusion With CT(Postoperative 6 Months) — 26; 28 participants
Preparation for Colonoscopy
Primary: The Quality of the Colon Preparation Will be Graded Using the Boston Bowel Preparation Scale — 7.86; 8.05; 7.99 units on a scale
Superficial Thrombophlebitis · Upper Extremity Superficial Thrombophlebitis · Lower Extremity Superficial Thrombophlebitis
Primary: Thrombosis Progression and Venous Thromboembolism (VTE) — 4; 0; 0; 0 participants
Influenza, Human
Primary: The Percentage of Evaluable Participants Achieving Seroconversion or Significant Increase in Antibody Titre. — 79.7; 55.9; 86.4; 64.4 percentage of participants
Syncope
Primary: Syncope Recurrence Rate — 57; 25 percentage of participants — p=0.04
Blood Pressure
Primary: Sitting Systolic Blood Pressure on Automated Measurement — 127.2; 134.1 mmHg